Dalton Greiner Hartman Maher & Co. Reduces Holdings in Merit Medical Systems, Inc. (MMSI)

Dalton Greiner Hartman Maher & Co. cut its holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 24.1% during the 4th quarter, HoldingsChannel reports. The fund owned 374,052 shares of the medical instruments supplier’s stock after selling 118,967 shares during the quarter. Dalton Greiner Hartman Maher & Co.’s holdings in Merit Medical Systems were worth $16,159,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the business. Vanguard Group Inc. raised its position in Merit Medical Systems by 4.5% in the second quarter. Vanguard Group Inc. now owns 4,374,628 shares of the medical instruments supplier’s stock worth $166,893,000 after acquiring an additional 187,745 shares in the last quarter. Dimensional Fund Advisors LP raised its position in Merit Medical Systems by 0.7% in the second quarter. Dimensional Fund Advisors LP now owns 2,694,722 shares of the medical instruments supplier’s stock worth $102,803,000 after acquiring an additional 19,257 shares in the last quarter. Janus Henderson Group PLC raised its position in Merit Medical Systems by 922.3% in the second quarter. Janus Henderson Group PLC now owns 1,533,513 shares of the medical instruments supplier’s stock worth $58,504,000 after acquiring an additional 1,383,513 shares in the last quarter. State Street Corp raised its position in Merit Medical Systems by 9.9% in the second quarter. State Street Corp now owns 1,339,547 shares of the medical instruments supplier’s stock worth $51,105,000 after acquiring an additional 120,759 shares in the last quarter. Finally, Macquarie Group Ltd. raised its position in Merit Medical Systems by 12.2% in the second quarter. Macquarie Group Ltd. now owns 1,122,457 shares of the medical instruments supplier’s stock worth $42,822,000 after acquiring an additional 122,138 shares in the last quarter. Hedge funds and other institutional investors own 90.65% of the company’s stock.

Shares of Merit Medical Systems, Inc. (NASDAQ MMSI) opened at $44.10 on Thursday. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.43 and a current ratio of 2.78. The stock has a market capitalization of $2,250.00, a PE ratio of 73.50, a price-to-earnings-growth ratio of 2.61 and a beta of 1.23. Merit Medical Systems, Inc. has a twelve month low of $24.23 and a twelve month high of $46.40.

Merit Medical Systems (NASDAQ:MMSI) last posted its quarterly earnings data on Wednesday, October 25th. The medical instruments supplier reported $0.32 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.30 by $0.02. The firm had revenue of $179.30 million for the quarter, compared to the consensus estimate of $181.28 million. Merit Medical Systems had a return on equity of 9.86% and a net margin of 4.06%. The business’s revenue for the quarter was up 14.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.26 EPS. equities analysts expect that Merit Medical Systems, Inc. will post 1.27 earnings per share for the current year.

In other Merit Medical Systems news, Director Franklin J. Miller sold 10,000 shares of Merit Medical Systems stock in a transaction dated Saturday, December 29th. The stock was sold at an average price of $43.93, for a total transaction of $439,300.00. Following the transaction, the director now owns 21,244 shares of the company’s stock, valued at approximately $933,248.92. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Kent W. Stanger sold 9,082 shares of Merit Medical Systems stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $44.90, for a total value of $407,781.80. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 32,000 shares of company stock worth $1,416,379. Company insiders own 5.00% of the company’s stock.

Several equities research analysts have commented on MMSI shares. Zacks Investment Research cut shares of Merit Medical Systems from a “buy” rating to a “hold” rating in a research report on Tuesday, October 3rd. Canaccord Genuity reiterated a “buy” rating and issued a $45.00 price target on shares of Merit Medical Systems in a research report on Sunday, October 8th. SunTrust Banks set a $47.00 price objective on Merit Medical Systems and gave the stock a “buy” rating in a report on Thursday, November 16th. ValuEngine upgraded Merit Medical Systems from a “hold” rating to a “buy” rating in a report on Tuesday, November 21st. Finally, Wells Fargo & Co restated an “outperform” rating and set a $51.00 price objective (up previously from $46.00) on shares of Merit Medical Systems in a report on Thursday, November 30th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $43.77.

ILLEGAL ACTIVITY WARNING: This report was reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this report on another site, it was stolen and republished in violation of US & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.com-unik.info/2018/01/11/dalton-greiner-hartman-maher-co-reduces-holdings-in-merit-medical-systems-inc-mmsi.html.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI).

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit